KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Receivables (2016 - 2026)

Bristol Myers Squibb has reported Receivables over the past 18 years, most recently at $10.8 billion for Q1 2026.

  • Quarterly Receivables fell 13.95% to $10.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $10.8 billion through Mar 2026, down 13.95% year-over-year, with the annual reading at $13.2 billion for FY2025, 18.89% up from the prior year.
  • Receivables was $10.8 billion for Q1 2026 at Bristol Myers Squibb, down from $13.2 billion in the prior quarter.
  • Over five years, Receivables peaked at $13.2 billion in Q4 2025 and troughed at $8.9 billion in Q1 2022.
  • The 5-year median for Receivables is $11.1 billion (2024), against an average of $11.5 billion.
  • Year-over-year, Receivables rose 24.74% in 2023 and then dropped 14.1% in 2024.
  • A 5-year view of Receivables shows it stood at $10.4 billion in 2022, then increased by 24.74% to $13.0 billion in 2023, then dropped by 14.1% to $11.1 billion in 2024, then increased by 18.89% to $13.2 billion in 2025, then dropped by 18.47% to $10.8 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Receivables are $10.8 billion (Q1 2026), $13.2 billion (Q4 2025), and $13.2 billion (Q3 2025).